Originalbeitrag in Fachzeitschrift
Preserved bevacizumab (Avastin®) eye drops for application in multidose containers - an in-vitro characterisation
Lessiak U, Brandstoetter T, Nell B, Klein K, Mlynek G, Wimmer L, et al. Preserved bevacizumab (Avastin®) eye drops for application in multidose containers - an in-vitro characterisation. BMC Veterinary Research. 2025;21(1):129. doi:https://doi.org/10.1186/s12917-025-04592-4
BOKU Autoren
Georg Mlynek
Mag. Georg Mlynek Ph.D.
